Format
Sort by
Items per page

Send to

Choose Destination

Best matches for glutamate receptor AND n-methyl-d-aspartate receptors AND rna, messenger AND schizophrenia:

Search results

Items: 1 to 20 of 92

1.

A quantitative review of the postmortem evidence for decreased cortical N-methyl-D-aspartate receptor expression levels in schizophrenia: How can we link molecular abnormalities to mismatch negativity deficits?

Catts VS, Lai YL, Weickert CS, Weickert TW, Catts SV.

Biol Psychol. 2016 Apr;116:57-67. doi: 10.1016/j.biopsycho.2015.10.013. Epub 2015 Nov 10. Review.

2.

IRSp53/BAIAP2 in dendritic spine development, NMDA receptor regulation, and psychiatric disorders.

Kang J, Park H, Kim E.

Neuropharmacology. 2016 Jan;100:27-39. doi: 10.1016/j.neuropharm.2015.06.019. Epub 2015 Aug 12. Review.

3.

Polymorphisms in MicroRNA Genes And Genes Involving in NMDAR Signaling and Schizophrenia: A Case-Control Study in Chinese Han Population.

Zhang Y, Fan M, Wang Q, He G, Fu Y, Li H, Yu S.

Sci Rep. 2015 Aug 10;5:12984. doi: 10.1038/srep12984.

4.

Neuregulin 1 expression and electrophysiological abnormalities in the Neuregulin 1 transmembrane domain heterozygous mutant mouse.

Long LE, Anderson P, Frank E, Shaw A, Liu S, Huang XF, Pinault D, Karl T, O'Brien TJ, Shannon Weickert C, Jones NC.

PLoS One. 2015 May 19;10(5):e0124114. doi: 10.1371/journal.pone.0124114. eCollection 2015.

5.

Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice.

Gomes FV, Issy AC, Ferreira FR, Viveros MP, Del Bel EA, Guimarães FS.

Int J Neuropsychopharmacol. 2014 Oct 31;18(5). pii: pyu041. doi: 10.1093/ijnp/pyu041.

6.

The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies.

Hu W, MacDonald ML, Elswick DE, Sweet RA.

Ann N Y Acad Sci. 2015 Mar;1338:38-57. doi: 10.1111/nyas.12547. Epub 2014 Oct 14. Review.

7.

Modified neocortical and cerebellar protein expression and morphology in adult rats following prenatal inhibition of the kynurenine pathway.

Pisar M, Forrest CM, Khalil OS, McNair K, Vincenten MC, Qasem S, Darlington LG, Stone TW.

Brain Res. 2014 Aug 12;1576:1-17. doi: 10.1016/j.brainres.2014.06.016. Epub 2014 Jun 21.

PMID:
24956103
8.

White matter injuries induced by MK-801 in a mouse model of schizophrenia based on NMDA antagonism.

Xiu Y, Kong XR, Zhang L, Qiu X, Chao FL, Peng C, Gao Y, Huang CX, Wang SR, Tang Y.

Anat Rec (Hoboken). 2014 Aug;297(8):1498-507. doi: 10.1002/ar.22942. Epub 2014 May 2.

9.

Neonatal exposure to MK-801 reduces mRNA expression of mGlu3 receptors in the medial prefrontal cortex of adolescent rats.

Uehara T, Sumiyoshi T, Rujescu D, Genius J, Matsuoka T, Takasaki I, Itoh H, Kurachi M.

Synapse. 2014 May;68(5):202-8. doi: 10.1002/syn.21734. Epub 2014 Feb 19.

PMID:
24549941
10.

De novo mutations in schizophrenia implicate synaptic networks.

Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P, Georgieva L, Rees E, Palta P, Ruderfer DM, Carrera N, Humphreys I, Johnson JS, Roussos P, Barker DD, Banks E, Milanova V, Grant SG, Hannon E, Rose SA, Chambert K, Mahajan M, Scolnick EM, Moran JL, Kirov G, Palotie A, McCarroll SA, Holmans P, Sklar P, Owen MJ, Purcell SM, O'Donovan MC.

Nature. 2014 Feb 13;506(7487):179-84. doi: 10.1038/nature12929. Epub 2014 Jan 22.

11.

D-serine deficiency attenuates the behavioral and cellular effects induced by the hallucinogenic 5-HT(2A) receptor agonist DOI.

Santini MA, Balu DT, Puhl MD, Hill-Smith TE, Berg AR, Lucki I, Mikkelsen JD, Coyle JT.

Behav Brain Res. 2014 Feb 1;259:242-6. doi: 10.1016/j.bbr.2013.11.022. Epub 2013 Nov 20.

12.

RETRACTED: Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients.

Rao JS, Kim HW, Harry GJ, Rapoport SI, Reese EA.

Schizophr Res. 2013 Jun;147(1):24-31. doi: 10.1016/j.schres.2013.02.017. Epub 2013 Apr 6.

13.

Analysis of Sp transcription factors in the postmortem brain of chronic schizophrenia: a pilot study of relationship to negative symptoms.

Pinacho R, Villalmanzo N, Roca M, Iniesta R, Monje A, Haro JM, Meana JJ, Ferrer I, Gill G, Ramos B.

J Psychiatr Res. 2013 Jul;47(7):926-34. doi: 10.1016/j.jpsychires.2013.03.004. Epub 2013 Mar 27.

PMID:
23540600
14.

Phencyclidine-induced decrease of synaptic connectivity via inhibition of BDNF secretion in cultured cortical neurons.

Adachi N, Numakawa T, Kumamaru E, Itami C, Chiba S, Iijima Y, Richards M, Katoh-Semba R, Kunugi H.

Cereb Cortex. 2013 Apr;23(4):847-58. doi: 10.1093/cercor/bhs074. Epub 2012 Mar 30.

PMID:
22467667
15.

Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes.

Wonodi I, Stine OC, Sathyasaikumar KV, Roberts RC, Mitchell BD, Hong LE, Kajii Y, Thaker GK, Schwarcz R.

Arch Gen Psychiatry. 2011 Jul;68(7):665-74. doi: 10.1001/archgenpsychiatry.2011.71.

16.

NMDA receptor regulates migration of newly generated neurons in the adult hippocampus via Disrupted-In-Schizophrenia 1 (DISC1).

Namba T, Ming GL, Song H, Waga C, Enomoto A, Kaibuchi K, Kohsaka S, Uchino S.

J Neurochem. 2011 Jul;118(1):34-44. doi: 10.1111/j.1471-4159.2011.07282.x. Epub 2011 May 19.

17.

Expression of parvalbumin and glutamic acid decarboxylase-67 after acute administration of MK-801. Implications for the NMDA hypofunction model of schizophrenia.

Romón T, Mengod G, Adell A.

Psychopharmacology (Berl). 2011 Sep;217(2):231-8. doi: 10.1007/s00213-011-2268-6. Epub 2011 Apr 5.

PMID:
21465242
18.

Strain dependent effects of prenatal stress on gene expression in the rat hippocampus.

Neeley EW, Berger R, Koenig JI, Leonard S.

Physiol Behav. 2011 Aug 3;104(2):334-9. doi: 10.1016/j.physbeh.2011.02.032. Epub 2011 Mar 4.

19.

An animal model of schizophrenia based on chronic LSD administration: old idea, new results.

Marona-Lewicka D, Nichols CD, Nichols DE.

Neuropharmacology. 2011 Sep;61(3):503-12. doi: 10.1016/j.neuropharm.2011.02.006. Epub 2011 Feb 23.

20.

Subchronic administration of ketamine decreases the mRNA expression of serine racemase in rat brain.

Watanabe M, Yoshikawa M, Takeyama K, Hashimoto A, Kobayashi H, Suzuki T.

Tokai J Exp Clin Med. 2010 Dec 20;35(4):137-43.

Supplemental Content

Loading ...
Support Center